is tirzepatide for type 2 diabetes Peptide of the Week: Tirzepatide, a Game Changer and Obesity Management NICE recommends Lilly's tirzepatide for
Description
Down 40 pounds at my last shot of month two
Retatrutide currently progresses through Phase 3 clinical trials, which typically require 18-24 months for completion plus additional time for FDA and Health Canada review
The ELISA plate is dismounted
Both are injectable medications originally developed for type 2 diabetes that also produce significant weight loss
The medication starts with an initial dose of 2.5 mg weekly with possible increments in 2.5 mg steps to a maximum of 15 mg
